ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

No reported Stock-Based Compensation figures are available to summarize.

Stock-Based Compensation history

Currency unavailable · from the cash flow

No Stock-Based Compensation data reported for this period type.

Stock-Based Compensation vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Stock-Based Compensation for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MGTXMeiraGTx Holdings plcLTM Mar 2026$47.93M USD+107.3%-8.3%60.1%
PRMEPrime Medicine, Inc.LTM Mar 2026$28.23M USD+6.4%+65.5%699.8%
STOKStoke Therapeutics, Inc.LTM Mar 2026$26.2M USD-9.4%+12.2%81.7%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026$23.07M USD-33.2%-6.0%50.9%
WVEWave Life Sciences Ltd.LTM Mar 2026$21.73M USD+42.8%—30.3%
SLNSilence Therapeutics plcLTM Mar 2026$14.34M USD—-14.0%1556.3%
BNTCBenitec Biopharma Inc.LTM Mar 2026$12.56M USD+183.6%+171.6%—
RNAAtrium Therapeutics, Inc.FY2025$7.68M USD——41.2%
PRQRProQR Therapeutics N.V.LTM Mar 2026€2.03M EUR-21.0%—15.1%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —+6.4%+3.1%55.5%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.